Structure-activity relationships of 2-pyrimidinecarbohydrazides as utrophin modulators for the potential treatment of Duchenne muscular dystrophy-Reference-Cited by-同舟云学术

Structure-activity relationships of 2-pyrimidinecarbohydrazides as utrophin modulators for the potential treatment of Duchenne muscular dystrophy

Published:2022-09 Issue: Volume:69 Page:116812
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Chatzopoulou Maria,Conole Daniel,Emer Enrico,Rowley Jessica A.,Willis Nicky J.,Squire Sarah E.,Gill Becky,Brough Steve,Wilson Francis X.,Wynne Graham M.,Davies Stephen G.,Davies Kay E.,Russell Angela J.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference26 articles.

1. New variants, challenges and pitfalls in DMD genotyping: implications in diagnosis, prognosis and therapy;Santos;J Hum Genet,2014

2. Pharmacological advances for treatment in Duchenne muscular dystrophy;Guiraud;Curr Opin Pharmacol,2017

3. The potential of utrophin modulators for the treatment of Duchenne muscular dystrophy;Guiraud;Expert Opin Orphan Drugs,2018

4. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene;Monaco;Nature,1986

5. Birnkrant DJ, Bushby K, Bann, CM, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol 2018;17:251–67. https://doi.org/10.1016/S1474-4422(18)30024-3.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 3D-QSAR Modeling on 2-Pyrimidine Carbohydrazides as Utrophin Modulators for the Treatment of Duchenne Muscular Dystrophy by Combining CoMFA, CoMSIA, and Molecular Docking Studies;ACS Omega;2024-05-31

2. Duchenne muscular dystrophy: pathogenesis and promising therapies;Journal of Neurology;2023-06-01

3. CONVENTIONAL APPROACHES TO THE THERAPY OF HEREDITARY MYOPATHIES;Pharmacy & Pharmacology;2022-12-11